Literature DB >> 23108647

Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice.

Frederique Yiannikouris1, Manisha Gupte, Kelly Putnam, Sean Thatcher, Richard Charnigo, Debra L Rateri, Alan Daugherty, Lisa A Cassis.   

Abstract

Previous studies demonstrated that diet-induced obesity increased plasma angiotensin II concentrations and elevated systolic blood pressures in male mice. Adipocytes express angiotensinogen and secrete angiotensin peptides. We hypothesize that adipocyte-derived angiotensin II mediates obesity-induced increases in systolic blood pressure in male high fat-fed C57BL/6 mice. Systolic blood pressure was measured by radiotelemetry during week 16 of low-fat or high-fat feeding in Agt(fl/fl) and adipocyte angiotensinogen-deficient mice (Agt(aP2)). Adipocyte angiotensinogen deficiency had no effect on diet-induced obesity. Basal 24-hour systolic blood pressure was not different in low fat-fed Agt(fl/fl) compared with Agt(aP2) mice (124 ± 3 versus 128 ± 3 mm Hg, respectively). In Agt(fl/fl) mice, high-fat feeding significantly increased systolic blood pressure (24 hours; 134 ± 2 mm Hg; P<0.05). In contrast, high fat-fed Agt(aP2) mice did not exhibit an increase in systolic blood pressure (126 ± 2 mm Hg). Plasma angiotensin II concentrations were increased by high-fat feeding in Agt(fl/fl) mice (low fat, 32 ± 14; high fat, 219 ± 58 pg/mL; P<0.05). In contrast, high fat-fed Agt(aP2) mice did not exhibit elevated plasma angiotensin II concentrations (high fat, 18 ± 7 pg/mL). Similarly, adipose tissue concentrations of angiotensin II were significantly decreased in low fat- and high fat-fed Agt(aP2) mice compared with controls. In conclusion, adipocyte angiotensinogen deficiency prevented high fat-induced elevations in plasma angiotensin II concentrations and systolic blood pressure. These results suggest that adipose tissue serves as a major source of angiotensin II in the development of obesity hypertension.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108647      PMCID: PMC3517298          DOI: 10.1161/HYPERTENSIONAHA.112.192690

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  43 in total

Review 1.  Do cardiac and perivascular adipose tissue play a role in atherosclerosis?

Authors:  Gianluca Iacobellis; Yu-Jing Gao; Arya M Sharma
Journal:  Curr Diab Rep       Date:  2008-02       Impact factor: 4.810

2.  Local renin angiotensin expression regulates human mesenchymal stem cell differentiation to adipocytes.

Authors:  Kenichi Matsushita; Yaojiong Wu; Yoshihisa Okamoto; Richard E Pratt; Victor J Dzau
Journal:  Hypertension       Date:  2006-10-23       Impact factor: 10.190

3.  Haplotypes of angiotensinogen in essential hypertension.

Authors:  X Jeunemaitre; I Inoue; C Williams; A Charru; J Tichet; M Powers; A M Sharma; A P Gimenez-Roqueplo; A Hata; P Corvol; J M Lalouel
Journal:  Am J Hum Genet       Date:  1997-06       Impact factor: 11.025

4.  AT1-receptor antagonism reverses the blood pressure elevation associated with diet-induced obesity.

Authors:  Carine M Boustany; David R Brown; David C Randall; Lisa A Cassis
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2005-03-17       Impact factor: 3.619

Review 5.  Insulin resistance in hypertension and cardiovascular disease.

Authors:  Valéria Lamounier-Zepter; Monika Ehrhart-Bornstein; Stefan R Bornstein
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2006-09       Impact factor: 4.690

6.  Weight loss and the renin-angiotensin-aldosterone system.

Authors:  Stefan Engeli; Jana Böhnke; Kerstin Gorzelniak; Jürgen Janke; Petra Schling; Michael Bader; Friedrich C Luft; Arya M Sharma
Journal:  Hypertension       Date:  2005-01-03       Impact factor: 10.190

7.  Morbid obesity, hypertensive disease and the renin-angiotensin-aldosterone axis.

Authors:  M Ruano; V Silvestre; R Castro; M C G García-Lescún; A Rodríguez; A Marco; G García-Blanch
Journal:  Obes Surg       Date:  2005-05       Impact factor: 4.129

8.  Characterization of renin activity in brown adipose tissue.

Authors:  U Shenoy; L Cassis
Journal:  Am J Physiol       Date:  1997-03

Review 9.  Local adipose tissue renin-angiotensin system.

Authors:  Lisa A Cassis; Sara B Police; Frederique Yiannikouris; Sean E Thatcher
Journal:  Curr Hypertens Rep       Date:  2008-04       Impact factor: 5.369

10.  Localization of angiotensinogen messenger RNA in rat aorta.

Authors:  L A Cassis; K R Lynch; M J Peach
Journal:  Circ Res       Date:  1988-06       Impact factor: 17.367

View more
  59 in total

1.  IgG receptor FcγRIIB plays a key role in obesity-induced hypertension.

Authors:  Nathan C Sundgren; Wanpen Vongpatanasin; Brigid-Meghan D Boggan; Keiji Tanigaki; Ivan S Yuhanna; Ken L Chambliss; Chieko Mineo; Philip W Shaul
Journal:  Hypertension       Date:  2014-11-03       Impact factor: 10.190

2.  Novel mechanism of blood pressure regulation by forkhead box class O1-mediated transcriptional control of hepatic angiotensinogen.

Authors:  Yajuan Qi; Kebin Zhang; Yuxin Wu; Zihui Xu; Qian Chen Yong; Rajesh Kumar; Kenneth M Baker; Qinglei Zhu; Shouwen Chen; Shaodong Guo
Journal:  Hypertension       Date:  2014-07-28       Impact factor: 10.190

Review 3.  Hypertension in HIV-Infected Adults: Novel Pathophysiologic Mechanisms.

Authors:  Sasha A Fahme; Gerald S Bloomfield; Robert Peck
Journal:  Hypertension       Date:  2018-05-18       Impact factor: 10.190

4.  Canagliflozin Prevents Intrarenal Angiotensinogen Augmentation and Mitigates Kidney Injury and Hypertension in Mouse Model of Type 2 Diabetes Mellitus.

Authors:  T Cooper Woods; Ryousuke Satou; Kayoko Miyata; Akemi Katsurada; Courtney M Dugas; Natasha C Klingenberg; Vivian A Fonseca; L Gabriel Navar
Journal:  Am J Nephrol       Date:  2019-03-28       Impact factor: 3.754

Review 5.  The Role of Aldosterone in Obesity-Related Hypertension.

Authors:  Wakako Kawarazaki; Toshiro Fujita
Journal:  Am J Hypertens       Date:  2016-02-28       Impact factor: 2.689

Review 6.  Anti-hypertensive drug treatment of patients with and the metabolic syndrome and obesity: a review of evidence, meta-analysis, post hoc and guidelines publications.

Authors:  Jonathan G Owen; Efrain Reisin
Journal:  Curr Hypertens Rep       Date:  2015-06       Impact factor: 5.369

Review 7.  Neuroimmune communication in hypertension and obesity: a new therapeutic angle?

Authors:  Annette D de Kloet; Eric G Krause; Peng D Shi; Jasenka Zubcevic; Mohan K Raizada; Colin Sumners
Journal:  Pharmacol Ther       Date:  2013-02-28       Impact factor: 12.310

Review 8.  Animal models in obesity and hypertension.

Authors:  Gabriella Segal-Lieberman; Talma Rosenthal
Journal:  Curr Hypertens Rep       Date:  2013-06       Impact factor: 5.369

Review 9.  Opposing tissue-specific roles of angiotensin in the pathogenesis of obesity, and implications for obesity-related hypertension.

Authors:  Nicole K Littlejohn; Justin L Grobe
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2015-10-21       Impact factor: 3.619

10.  Bmal1 in Perivascular Adipose Tissue Regulates Resting-Phase Blood Pressure Through Transcriptional Regulation of Angiotensinogen.

Authors:  Lin Chang; Wenhao Xiong; Xiangjie Zhao; Yanbo Fan; Yanhong Guo; Minerva Garcia-Barrio; Jifeng Zhang; Zhisheng Jiang; Jiandie D Lin; Y Eugene Chen
Journal:  Circulation       Date:  2018-01-25       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.